These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7932619)

  • 1. Human urokinase, a serine proteinase, potentiates the in-vitro growth of micro-organisms which commonly infect burn patients.
    Hart DA; Woods DE
    J Med Microbiol; 1994 Oct; 41(4):264-71. PubMed ID: 7932619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase enhances the growth of Pseudomonas spp. in vitro under nonshaking (oxygen limited) conditions.
    Hart DA; Woods DE
    Can J Microbiol; 1994 Apr; 40(4):292-7. PubMed ID: 8039052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAP-containing dressings exhibit sustained antimicrobial effects over 7 days in vitro.
    Wiegand C; Abel M; Muldoon J; Ruth P; Hipler UC
    J Wound Care; 2013 Mar; 22(3):120, 122-4, 126-7. PubMed ID: 23665730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of simultaneous inoculation of Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans on rodent burn wounds.
    Brandenburg KS; Weaver AJ; Karna SLR; Leung KP
    Burns; 2021 Dec; 47(8):1818-1832. PubMed ID: 33771422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative roles of burn injury, wound colonization, and wound infection in induction of alterations of complement function in a guinea pig model of burn injury.
    Bjornson AB; Bjornson HS; Lincoln NA; Altemeier WA
    J Trauma; 1984 Feb; 24(2):106-15. PubMed ID: 6420578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
    Ziółkowski G; Dudzińska G; Sakiel S
    Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protease activity of strains of Pseudomonas aeruginosa isolated from different sources].
    Brodinova NS; Luchina TIa; Adzhieva AA; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):54-7. PubMed ID: 6800163
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth of microorganisms in soybean oil emulsion and clinical implications.
    Deitel M; Fuksa M; Kaminsky VM; Vasic V
    Int Surg; 1979 Apr; 64(3):27-32. PubMed ID: 119714
    [No Abstract]   [Full Text] [Related]  

  • 9. [The reciprocal effect of the causative agents in a mixed infection in burn injury].
    Bel'skiĭ VV; Shatalova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):3-7. PubMed ID: 10852039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urokinase on the extracellular virulence properties of Pseudomonas aeruginosa and Burkholderia cepacia.
    Heys SJ; Orton SL; Allison DG
    J Basic Microbiol; 1999; 39(1):17-24. PubMed ID: 10071863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida albicans growth studies: a hypothesis for the pathogenesis of Candida infections in burns.
    Neely AN; Orloff MM; Holder IA
    J Burn Care Rehabil; 1992; 13(3):323-9. PubMed ID: 1377693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis.
    Leduc D; Beaufort N; de Bentzmann S; Rousselle JC; Namane A; Chignard M; Pidard D
    Infect Immun; 2007 Aug; 75(8):3848-58. PubMed ID: 17517866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC; Agarwal N; Agarwal S
    Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of some plant extracts and antibiotics on Pseudomonas aeruginosa isolated from various burn cases.
    Al-Saimary IE; Bakr SS; Jaffar T; Al-Saimary AE; Salim H; Al-Muosawi R
    Saudi Med J; 2002 Jul; 23(7):802-5. PubMed ID: 12174229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multidrug-resistant organisms recovered at a military burn center.
    Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
    Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR.
    Nanvazadeh F; Khosravi AD; Zolfaghari MR; Parhizgari N
    Burns; 2013 Nov; 39(7):1409-13. PubMed ID: 23773789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of histone H1.2 in infected burn wounds.
    Jacobsen F; Baraniskin A; Mertens J; Mittler D; Mohammadi-Tabrisi A; Schubert S; Soltau M; Lehnhardt M; Behnke B; Gatermann S; Steinau HU; Steinstraesser L
    J Antimicrob Chemother; 2005 May; 55(5):735-41. PubMed ID: 15772144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Coetzee E; Rode H; Kahn D
    S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial infections in burns patients: a three years study at RML Hospital, Delhi.
    Sharma S; Hans C
    J Commun Dis; 1996 Jun; 28(2):101-6. PubMed ID: 8810144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.